Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Intensive Care Medicine|August 7, 2004
Acute respiratory failure from abused substancesKevin C Wilson, Jussi J Saukkonen
Infection and Immunity|March 16, 2002
Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growthJussi J Saukkonen, Beth Bazydlo, Michael Thomas, et al.
American Journal of Respiratory and Critical Care Medicine|July 1, 2006
Predicting non-completion of treatment for latent tuberculous infection: a prospective surveyFred K Shieh, Graham Snyder, C Robert Horsburgh, et al.
American Journal of Respiratory and Critical Care Medicine|October 13, 2004
Recurrent tuberculosis in the United States and Canada: relapse or reinfection?Robert M Jasmer, Lorna Bozeman, Kevin Schwartzman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2004
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trialRobert M Jasmer, David C Snyder, Jussi J Saukkonen, et al.
Annals of Internal Medicine|October 16, 2002
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trialRobert M Jasmer, Jussi J Saukkonen, Henry M Blumberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 23, 2020
Community-acquired Pneumonia Guideline Recommendations-Impact of a Consensus-based Process versus Systematic ReviewsKevin C Wilson, Noah C Schoenberg, David L Cohn, et al.
Clinical Trials (London, England)|November 7, 2019
Nonparticipation reasons in a randomized international trial of a new latent tuberculosis infection regimenKimberley N Chapman Hedges, Andrey S Borisov, Jussi J Saukkonen, et al.
American Journal of Respiratory and Critical Care Medicine|October 6, 2006
An official ATS statement: hepatotoxicity of antituberculosis therapyJussi J Saukkonen, David L Cohn, Robert M Jasmer, et al.
American Journal of Respiratory and Critical Care Medicine|July 22, 2025
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice GuidelineJussi J Saukkonen, Raquel Duarte, Sonal S Munsiff, et al.
Pageof 1